Linked Life Data

17000936

Source:http://linkedlifedata.com/resource/pubmed/id/17000936

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
17
pubmed:dateCreated
2006-9-26
pubmed:abstractText
In addition to well-established secondary prevention benefits for atherosclerotic coronary artery disease, 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) are hypothesized to have short-term benefit in acute coronary syndrome (ACS), yet the data are inconsistent, with some trials underpowered to demonstrate therapeutic benefit. Our objective was to determine the effects of early, intensive statin therapy for ACS.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0003-9926
pubmed:author
pubmed:issnType
Print
pubmed:day
25
pubmed:volume
166
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1814-21
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed:year
2006
pubmed:articleTitle
The effect of early, intensive statin therapy on acute coronary syndrome: a meta-analysis of randomized controlled trials.
pubmed:affiliation
Department of Internal Medicine, General Internal Medicine, and Cardiology, Walter Reed Army Medical Center, Washington, DC, USA. edward.hulten@us.army.mil
pubmed:publicationType
Journal Article, Review, Meta-Analysis